THC THERAPEUTICS, INC. Derivative, Loss on Derivative
THC THERAPEUTICS, INC. reported Derivative, Loss on Derivative of -$12.18 thousand for the 12-month period ending 2020-07-31, per its 10-K filed 2020-11-04.
Discontinued › Notes
us-gaap:DerivativeLossOnDerivative · last filed 2020-11-04
- THC THERAPEUTICS, INC. derivative, loss on derivative for the quarter ending 2020-07-31 was $0.00, a 100.00% decline year-over-year.
- THC THERAPEUTICS, INC. derivative, loss on derivative for the quarter ending 2019-07-31 was $672.62K.
- THC THERAPEUTICS, INC. derivative, loss on derivative for the quarter ending 2019-04-30 was $304.72K.
- THC THERAPEUTICS, INC. derivative, loss on derivative for fiscal 2020 was -$12.18K, a 101.08% decline from fiscal 2019.
- THC THERAPEUTICS, INC. derivative, loss on derivative for fiscal 2019 was $1.13M.
| Period end | Derivative, Loss on Derivative 3 month | Derivative, Loss on Derivative 6 month | Derivative, Loss on Derivative 9 month | Derivative, Loss on Derivative 12 month | Derivative, Loss on Derivative 12 month as first filed |
|---|---|---|---|---|---|
| 2020-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-04 | -$12.18K 10-K · filed 2020-11-04 | |||
| 2020-04-30 | -$12.18K 10-Q · filed 2020-06-22 | ||||
| 2019-07-31 | $672.62K derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-04 | $977.34K derived: sum of 2 quarters · filed 2020-11-04 | $1.13M 10-K · filed 2020-11-04 | -$3.65M 10-K/A · filed 2019-11-18 | |
| 2019-04-30 | $304.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-22 | $459.64K 10-Q · filed 2020-06-22 | |||
| 2019-01-31 | $154.92K 10-Q · filed 2019-03-15 |